Hepatocellular carcinoma: epidemiology and clinical aspects.
Liver cancer is one of the most frequent solid cancers that kills more than 650,000 people around the world each year. Though great improvements have been done in last 10 years on the understanding the molecular mechanisms involved in liver oncogenesis, the prognosis of patients affected by liver cancer is still poor for most of them. Even in those where a relatively early diagnosis is done, the course of the disease is often fatal due to the underlying liver cirrhosis. In this review authors report the most recent findings on the pathogenesis of liver cancer and on therapeutic approaches, included those emerging from the most recent literature.
Mazzanti
Roberto
R
Department of Oncology, Azienda Ospedaliero-Universitaria Careggi, Istituto Toscano Tumori, University of Florence, Florence, Italy. roberto.mazzanti@unifi.it
Gramantieri
Laura
L
Bolondi
Luigi
L
D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D006518:Hepatitis Viruses / Q000502:physiology; D006801:Humans; D008099:Liver / Q000473:pathology / Q000601:surgery / Q000821:virology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D016031:Liver Transplantation; D012307:Risk Factors